As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on KYTX stock, giving a Buy rating on January 13.Stay Ahead of the ...

The first phase of Bennett's Village All-Abilities Play Space, a treehouse accommodating children regardless of disability, ...

Keros Therapeutics (KROS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong ...

PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services bas ...

Training these muscles together can lead to greater overall muscular strength and improved neuromuscular coordination (muscle ... those muscles generate myonuclei—cells that contain the DNA needed to ...

Incretin-mimetic drugs contribute to dramatic weight loss, but this does not solely mean fat loss. In this article, we ...

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...

Computer Model as Guide for Treatment Selection in Chronic Myelogenous Leukemia: Study FindsResearchers, in a new study, used ...